ESR1 and cancer: In view of the regulatory function in this TME component, several potential combinations of estrogen/ER-target therapy for cancer treatment have been tested in various research, including the immune checkpoint inhibitor therapy [142], immune-modulating therapy [143], and cancer vaccination therapy [144].